{
    "id": 26641,
    "fullName": "CD276 positive",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "CD276 positive indicates the presence of the CD276 gene, mRNA, and/or protein.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 80381,
        "geneSymbol": "CD276",
        "terms": [
            "CD276",
            "4Ig-B7-H3",
            "B7-H3",
            "B7H3",
            "B7RP-2"
        ]
    },
    "variant": "positive",
    "createDate": "06/02/2017",
    "updateDate": "11/28/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 15181,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MGC018 demonstrated anti-tumor activity in cell line xenograft models of CD276 (B7-H3)-positive melanoma (Cancer Res 2018;78(13 Suppl):Abstract nr 820).",
            "molecularProfile": {
                "id": 27908,
                "profileName": "CD276 positive"
            },
            "therapy": {
                "id": 7459,
                "therapyName": "MGC018",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12775,
                    "pubMedId": null,
                    "title": "Preclinical development of MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer",
                    "url": "http://cancerres.aacrjournals.org/content/78/13_Supplement/820"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15180,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MGC018 demonstrated anti-tumor activity in cell line xenograft models of CD276 (B7-H3)-positive ovarian cancer (Cancer Res 2018;78(13 Suppl):Abstract nr 820).",
            "molecularProfile": {
                "id": 27908,
                "profileName": "CD276 positive"
            },
            "therapy": {
                "id": 7459,
                "therapyName": "MGC018",
                "synonyms": null
            },
            "indication": {
                "id": 2394,
                "name": "ovarian cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12775,
                    "pubMedId": null,
                    "title": "Preclinical development of MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer",
                    "url": "http://cancerres.aacrjournals.org/content/78/13_Supplement/820"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15178,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MGC018 demonstrated anti-tumor activity in cell line xenograft models of CD276 (B7-H3)-positive breast cancer (Cancer Res 2018;78(13 Suppl):Abstract nr 820).",
            "molecularProfile": {
                "id": 27908,
                "profileName": "CD276 positive"
            },
            "therapy": {
                "id": 7459,
                "therapyName": "MGC018",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12775,
                    "pubMedId": null,
                    "title": "Preclinical development of MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer",
                    "url": "http://cancerres.aacrjournals.org/content/78/13_Supplement/820"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15179,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MGC018 demonstrated anti-tumor activity in cell line xenograft models of CD276 (B7-H3)-positive lung cancer (Cancer Res 2018;78(13 Suppl):Abstract nr 820).",
            "molecularProfile": {
                "id": 27908,
                "profileName": "CD276 positive"
            },
            "therapy": {
                "id": 7459,
                "therapyName": "MGC018",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 12775,
                    "pubMedId": null,
                    "title": "Preclinical development of MGC018, a duocarmycin-based antibody-drug conjugate targeting B7-H3 for solid cancer",
                    "url": "http://cancerres.aacrjournals.org/content/78/13_Supplement/820"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27908,
            "profileName": "CD276 positive",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}